These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1687783)

  • 1. Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosis.
    Riederer P; Lange KW; Kornhuber J; Jellinger K
    J Neural Transm Suppl; 1991; 34():203-10. PubMed ID: 1687783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia.
    Riederer P; Lange KW; Kornhuber J; Danielczyk W
    Arzneimittelforschung; 1992 Feb; 42(2A):265-8. PubMed ID: 1350197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity.
    Manev H; Costa E; Wroblewski JT; Guidotti A
    FASEB J; 1990 Jul; 4(10):2789-97. PubMed ID: 2165013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside-mediated protection from glutamate-induced neuronal death.
    Manev H; Favaron M; Vicini S; Guidotti A
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):475-88. PubMed ID: 1983378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium and glutamate-induced cortical neuronal death.
    Choi DW; Hartley DM
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():23-34. PubMed ID: 8093332
    [No Abstract]   [Full Text] [Related]  

  • 6. Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?
    Lawlor BA; Davis KL
    Biol Psychiatry; 1992 Feb; 31(4):337-50. PubMed ID: 1348429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.
    Heresco-Levy U
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1113-23. PubMed ID: 14642971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metabotropic glutamate receptor agonist does not mediate neuronal degeneration in cortical culture.
    Koh JY; Palmer E; Lin A; Cotman CW
    Brain Res; 1991 Oct; 561(2):338-43. PubMed ID: 1666330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia: a subcortical neurotransmitter imbalance syndrome?
    Carlsson M; Carlsson A
    Schizophr Bull; 1990; 16(3):425-32. PubMed ID: 1981107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate transmission and toxicity in Alzheimer's disease.
    Greenamyre JT; Maragos WF; Albin RL; Penney JB; Young AB
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):421-30. PubMed ID: 2900537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate neurotoxicity and diseases of the nervous system.
    Choi DW
    Neuron; 1988 Oct; 1(8):623-34. PubMed ID: 2908446
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of glutamate in neurotransmission and in neurologic disease.
    Greenamyre JT
    Arch Neurol; 1986 Oct; 43(10):1058-63. PubMed ID: 2428340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.
    Grace AA
    Neuroscience; 1991; 41(1):1-24. PubMed ID: 1676137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia.
    Simpson MD; Slater P; Royston MC; Deakin JF
    Psychiatry Res; 1992 Jun; 42(3):273-82. PubMed ID: 1353892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate in the mammalian CNS.
    Sahai S
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):121-33. PubMed ID: 1981150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic factors in the selective vulnerability of hippocampal pyramidal neurons.
    Mattson MP; Guthrie PB; Kater SB
    Prog Clin Biol Res; 1989; 317():333-51. PubMed ID: 2690106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death.
    Manev H; Favaron M; Guidotti A; Costa E
    Mol Pharmacol; 1989 Jul; 36(1):106-12. PubMed ID: 2568579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate neurotoxicity and the inhibition of protein synthesis in the hippocampal slice.
    Vornov JJ; Coyle JT
    J Neurochem; 1991 Mar; 56(3):996-1006. PubMed ID: 1671589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains.
    Tsai G; Passani LA; Slusher BS; Carter R; Baer L; Kleinman JE; Coyle JT
    Arch Gen Psychiatry; 1995 Oct; 52(10):829-36. PubMed ID: 7575102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning of the genes for excitatory amino acid receptors.
    Henneberry RC
    Bioessays; 1992 Jul; 14(7):465-71. PubMed ID: 1359885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.